“Erectile dysfunction and testosterone deficiency.” Front Horm Res. “ Cost effectiveness of radical prostatectomy versus watchful waiting for non-screen detected prostate cancer: extrapolating from the Scandinavian trial” Submitted for publication.īlute M, Hakimian P, Kashanian J, Shteynshlyuger A, Lee M, Shabsigh R. “ The effect of PSA Screening on Quality Adjusted Life Years (QALY): a model based on the population based results from the ERSPC”. Counterpoint: Prostate carcinoma treatment for the young patient-The case for radical prostatectomy. Words of Wisdom: Re: Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era European Urology. “ Prostate cancer: to screen or not to screen?” in Advances and Controversies in Prostate Cancer, An Issue of Urologic Clinics By William K. “Familial Testicular Torsion in Three Consecutive Generations of First Degree Relatives.” J Pediatr Urol. “Cost Effectiveness of PSA Screening in the US: Extrapolating from the ERSPC Trial”. “ Familial testicular torsion: A meta analysis suggests inheritance.” J Pediatr Urol. 2013 Oct 9(5):683-90. “ A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report Of The ISPOR Oncology Good Outcomes Research Practices Working Group.” Value in Health V16(4):655-669, June 2013 Foley, PhD, Arijit Ganguli, MBA, PhD, Jonas de Souza MD, Alex Shteynshlyuger, MD.
Schulman, MA, Karina Berenson, MPH, Ya-Chen (Tina) Shih, PhD, Kathleen A.
0 kommentar(er)
